| Dolutegravir | 🇺🇸United States | 10MG, 5MG | film | Marketed | Laurus Generics INC |
| Dolutegravir Sodium | 🇺🇸United States | 10MG | tablet | Tentative approval | Macleods Pharms LTD |
| Dolutegravir Sodium | 🇺🇸United States | 10MG BASE, 25MG BASE, 50MG … | tablet | Tentative approval | Cipla LTD |
| Dolutegravir; RilpivirineCombination | 🇺🇸United States | 50MG/25MG | tablet | Tentative approval | Lupin LTD |
| Dolutegravir and LamivudineCombination | 🇺🇸United States | 300MG | tablet | Tentative approval | Emcure Pharms LTD |
| Dolutegravir;Lamivudine;Tenofovir AlafenamideCombination | 🇺🇸United States | 50MG; 300MG; 25MG | tablet | Tentative approval | Lupin Pharms |
| DovatoCombination | 🇺🇸United States | 50MG BASE; 300MG | tablet | Marketed | Viiv Hlthcare |
| Dolutegravir; Emtricitabine; Tenofovir AlafenamideCombination | 🇺🇸United States | 50MG; 200MG; 25MG | tablet | Tentative approval | Lupin LTD |
| Dolutegravir Sodium and Abacavir Sulfate and LamivudineCombination | 🇺🇸United States | 300MG, 600MG | tablet | Tentative approval | Cipla Limited |
| DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDECombination | 🇺🇸United States | 50MG/200MG/25MG | tablet | Tentative approval | Aurobindo Pharma USA |
| Dolutegravir; Lamivudine; Tenofovir Disoproxil FumarateCombination | 🇺🇸United States | 50MG; 300MG; 300MG, 50MG/300MG/300MG | tablet | Tentative approval | Laurus Labs LTD |
| Dolutegravir; Tenofovir Disoproxil Fumarate; LamivudineCombination | 🇺🇸United States | 50MG/300MG/300MG | tablet | Tentative approval | Strides Pharma |
| Dolutegravir, Lamivudine and Tenofovir Disoproxil FumarateCombination | 🇺🇸United States | 50MG; 300MG; 300MG, 50MG/300MG/300MG | tablet | Tentative approval | Lupin Pharms |
| Dolutegravir, Lamivudine, and Tenofovir Disoproxil FumarateCombination | 🇺🇸United States | 50MG; 300MG; 300MG | tablet | Tentative approval | Mylan Pharms INC |
| JulucaCombination | 🇺🇸United States | 50MG BASE; 25MG BASE | tablet | Marketed | Viiv Hlthcare |
| Tivicay | 🇺🇸United States | 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 50MG BASE | tablet | Marketed | Viiv Hlthcare |
| Tivicay PD | 🇺🇸United States | 5MG BASE | tablet, for suspension | Marketed | Viiv Hlthcare |
| Abacavir, Dolutegravir, LamivudineCombination | 🇺🇸United States | 300MG, 50MG | tablet | Tentative approval | Cipla Limited |
| Abacavir || Dolutegravir || LamivudineCombination | 🇺🇸United States | 300MG, 50MG, 600MG | tablet | Tentative approval | Emcure Pharms LTD |
| Abacavir; Dolutegravir; LamivudineCombination | 🇺🇸United States | 30MG, 5MG, 600MG; 50MG; 300MG … | tablet | Tentative approval | Laurus Labs LTD |
| Abacavir, Dolutegravir and LamivudineCombination | 🇺🇸United States | 30MG, 5MG | tablet | Tentative approval | Macleods Pharmaceuticals LTD |
| TriumeqCombination | 🇺🇸United States | 600MG BASE; 50MG BASE; 300MG | tablet | Marketed | Viiv Hlthcare |
| Triumeq PDCombination | 🇺🇸United States | 60MG BASE; 5MG BASE; 30MG | tablet, for suspension | Marketed | Viiv Hlthcare |
| Dolutegravir Lamivudine Tenofovir Alafenamide | 🇺🇸United States | 50MG BASE | tablet | Tentative approval | Cipla USA INC. |
